The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance

AAPS Journal

Volumn 15, Issue 1, 2013, Pages 258-266

  Gao, Mingming ^a   Liu, Dexi ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

diabetes; high fat diet induced obesity; liver X receptor; nuclear receptor; T0901317

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL 7ALPHA MONOOXYGENASE; FAS ANTIGEN; LIPID; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCOUPLING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; ENERGY METABOLISM; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; DIET, HIGH-FAT; EATING; ENERGY METABOLISM; FATTY LIVER; GLUCOSE; HYDROCARBONS, FLUORINATED; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORPHAN NUCLEAR RECEPTORS; PANCREAS; SULFONAMIDES;

EID: 84871990404     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-012-9429-3     Document Type: Article

References (33)

1. Yanovski SZ, Yanovski JA. Obesity prevalence in the United States - up, down, or sideways? N Engl J Med. 2011;364(11):987-9.
2. Wang Y, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6-28. (Pubitemid 47229643)
3. Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J. 2010;57(5):359-72.
4. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-7. (Pubitemid 34000780)
5. Kaiyala KJ, Schwartz MW. Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes. 2011;60(1):17-23.
6. Grun F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord. 2007;8(2):161-71. (Pubitemid 47434649)
7. Chiang JY. Nuclear receptor regulation of lipid metabolism: potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver diseases. Curr Opin Investig Drugs. 2005;6(10):994-1001. (Pubitemid 41535783)
8. Liu YY, Brent GA. Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab. 2010;21(3):166-73.
9. Chen Z, Vigueira PA, Chambers KT, Hall AM, Mitra MS, Qi N, et al. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor gamma-sparing thiazolidinedione. J Biol Chem. 2012;287(28):23537-48.
10. Miyazaki S, Taniguchi H, Moritoh Y, Tashiro F, Yamamoto T, Yamato E, et al. Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ss-cells. Diabetes. 2010;59(11):2854-61.
11. Faulds MH, Zhao C, Dahlman-Wright K. Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases. Curr Opin Pharmacol. 2010;10(6):692-7.
12. Edwards PA, Kast HR, Anisfeld AM. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res. 2002;43(1):2-12. (Pubitemid 34117211)
13. Liu Y, Yan C, Wang Y, Nakagawa Y, Nerio N, Anghel A, et al. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology. 2006;147(11):5061-8. (Pubitemid 44790557)
14. Cao GQ, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, et al. Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem. 2003;278(2):1131-6. (Pubitemid 36790794)
15. Babaya N, Fujisawa T, Nojima K, Itoi-Babaya M, Yamaji K, Yamada K, et al. Direct evidence for susceptibility genes for type 2 diabetes on mouse chromosomes 11 and 14. Diabetologia. 2010;53(7):1362-71.
16. Hirata A, Maeda N, Hiuge A, Hibuse T, Fujita K, Okada T, et al. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc Res. 2009;84(1):164-72.
17. Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, Park J, et al. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis - liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes. 2007;56(6):1534-43. (Pubitemid 46842606)
18. Porter RK. A new look at UCP 1. BBA-Bioenergetics. 2006;1757(5-6):446-8. (Pubitemid 43993859)
19. Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature. 2009;460(7259):1154-8.
20. Cheng Y, Meng QS, Wang CX, Li HK, Huang ZY, Chen SH, et al. Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes. 2010;59(1):17-25.
21. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res. 2008;79(2):208-17. (Pubitemid 351951611)
22. Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ. 2006;30(4):145-51. (Pubitemid 44749372)
23. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 2005;19(1):136-8. (Pubitemid 40069943)
24. Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem. 2007;282(1):743-51. (Pubitemid 47076632)
25. Gerin I, Dolinsky VW, Shackman JG, Kennedy RT, Chiang SH, Burant CF, et al. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem. 2005;280(24):23024-31. (Pubitemid 40861694)
26. Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A. 2003;100(9):5419-24. (Pubitemid 36542720)
27. Dalen KT, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI. Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha. J Biol Chem. 2003;278(48):48283-91. (Pubitemid 37526713)
28. Steffensen KR, Gustafsson JA. Putative metabolic effects of the liver X receptor (LXR). Diabetes. 2004;53 Suppl 1:S36-42.
29. Hu T, Foxworthy P, Siesky A, Ficorilli JV, Gao H, Li S, et al. Hepatic peroxisomal fatty acid beta-oxidation is regulated by liver X receptor alpha. Endocrinology. 2005;146(12):5380-7. (Pubitemid 41653052)
30. Harris RBS, Apolzan JW. Changes in glucose tolerance and leptin responsiveness of rats offered a choice of lard, sucrose, and chow. Am J Physiol Regul Integr. 2012;302(11):R1327-39.
31. Nolan MA, Sikorski MA, McKnight GS. The role of uncoupling protein 1 in the metabolism and adiposity of RII beta-protein kinase A-deficient mice. Mol Endocrinol. 2004;18(9):2302-11. (Pubitemid 39215258)
32. Chisholm JW, Hong J, Mills SA, Lawn RM. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J Lipid Res. 2003;44(11):2039-48. (Pubitemid 37509619)
33. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem. 2002;277(13):11019-25. (Pubitemid 34952859)